Elvium Life Sciences Announces Publication of New Data Analysis from Studies with FOQUEST® Controlled Release Capsules Examining Sleep Quality Outcomes in Adults with ADHD
Elvium Life Sciences Announces Publication of New Data Analysis from Studies with FOQUEST® Controlled Release Capsules Examining Sleep Quality Outcomes in Adults with ADHD Toronto, Ontario, August 25, 2021 – Elvium Life Sciences, an independent associated company of Purdue Pharma (Canada), announced the publication of post-hoc analyses of data from a randomized, double‑blind, 4-week, [...]